Analyses of biomarkers of exposure to nephrotoxic mycotoxins in a cohort of patients with renal tumours
Language English Country Germany Media print-electronic
Document type Journal Article
Grant support
001
World Health Organization - International
PubMed
31254204
DOI
10.1007/s12550-019-00365-9
PII: 10.1007/s12550-019-00365-9
Knihovny.cz E-resources
- Keywords
- Biomarkers, Citrinin, Dihydrocitrinone, Ochratoxin A, Renal carcinogenicity,
- MeSH
- Biomarkers blood urine MeSH
- Chromatography, Liquid MeSH
- Citrinin blood urine MeSH
- Adult MeSH
- Cohort Studies MeSH
- Middle Aged MeSH
- Humans MeSH
- Mycotoxins blood urine MeSH
- Kidney Neoplasms chemistry urine MeSH
- Ochratoxins blood urine MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Tandem Mass Spectrometry MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Czechoslovakia MeSH
- Names of Substances
- Biomarkers MeSH
- Citrinin MeSH
- Mycotoxins MeSH
- ochratoxin A MeSH Browser
- Ochratoxins MeSH
The Czech Republic occupies the first place in the world in the frequency of renal and other urinary tract tumours, but their aetiology is unknown. To explore whether carcinogenic and nephrotoxic mycotoxins may contribute to kidney diseases in the Czech population, biomarkers of ochratoxin A (OTA) and citrinin (CIT) exposure were determined in biological specimens from a cohort of 50 patients with malignant renal tumours. Biomarker analyses in blood and urine samples used validated targeted methods for measuring OTA and CIT plus dihydrocitrinone (DH-CIT) after enrichment of analytes by specific immunoaffinity clean-up. OTA and CIT plus its metabolite DH-CIT were frequently detected in patient urine samples (OTA 62%; CIT 91%; DH-CIT 100%). The concentration ranges in urine were 1-27.8 ng/L for OTA, 2-87 ng/L for CIT and 2-160 ng/L for DH-CIT. The analyses of blood samples revealed also a frequent co-occurrence of OTA and CIT, in the ranges of 40-870 ng/L serum for OTA and 21-182 ng/L plasma for CIT. This first analysis of biomarkers in blood and urine samples of Czech patients revealed no major differences in comparison with published data for the general healthy Czech and European populations. Nonetheless, a frequent co-occurrence of CIT and OTA biomarkers in patient samples may be of interest with regard to potential interactions with other risk factors for renal disease.
See more in PubMed
Chem Biol Interact. 2006 Jan 5;159(1):18-46 PubMed
Mol Nutr Food Res. 2005 Feb;49(2):118-30 PubMed
Microchem J. 1996 Nov;54(4):472-7 PubMed
Arh Hig Rada Toksikol. 2008 Mar;59(1):59-65 PubMed
Int J Hyg Environ Health. 2016 Mar;219(2):143-65 PubMed
Biomarkers. 2012 Nov;17(7):577-89 PubMed
Mycotoxin Res. 2018 Mar;34(1):59-67 PubMed
Crit Rev Toxicol. 2011 Mar;41(3):187-212 PubMed
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005 May;48(5):616-8 PubMed
Toxicol Lett. 2018 Jan 5;282:43-48 PubMed
Toxicol Lett. 2017 Jun 5;275:19-26 PubMed
Food Addit Contam. 2001 Dec;18(12):1088-93 PubMed
Nutr Res Rev. 2012 Jun;25(1):162-79 PubMed
Arch Toxicol. 2013 Jun;87(6):1087-94 PubMed
Mycotoxin Res. 2015 Feb;31(1):9-16 PubMed
Arch Toxicol. 2014 Mar;88(3):837-46 PubMed
Toxins (Basel). 2015 Sep 10;7(9):3608-35 PubMed
Arch Toxicol. 2015 Apr;89(4):573-8 PubMed
J Chromatogr B Biomed Appl. 1995 Apr 7;666(1):85-99 PubMed
Arch Toxicol. 2016 Nov;90(11):2683-2697 PubMed
Arch Toxicol. 2014 May;88(5):1097-107 PubMed
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2010 Feb;27(2):212-40 PubMed
Int J Epidemiol. 2000 Dec;29(6):1014-24 PubMed
Chem Res Toxicol. 2018 Nov 19;31(11):1109-1110 PubMed
J Am Soc Nephrol. 2007 Nov;18(11):2817-23 PubMed
Nat Rev Urol. 2010 May;7(5):245-57 PubMed
Mycotoxin Res. 2009 Dec;25(4):175-86 PubMed
Arh Hig Rada Toksikol. 2009 Dec;60(4):465-83 PubMed
Toxins (Basel). 2013 Sep 17;5(9):1574-86 PubMed
Hypertension. 2014 May;63(5):934-41 PubMed
Mol Nutr Food Res. 2006 May;50(6):513-8 PubMed
Food Chem Toxicol. 2013 Dec;62:427-31 PubMed
Int J Mol Sci. 2013 Sep 25;14(10):19416-33 PubMed
Food Addit Contam. 2002 Mar;19(3):282-302 PubMed
Environ Int. 2016 Dec;97:254-255 PubMed
Toxicol Sci. 2012 Jun;127(2):315-30 PubMed
Semin Oncol. 2016 Oct;43(5):566-574 PubMed
Mycotoxin Res. 2016 Aug;32(3):163-72 PubMed
Toxins (Basel). 2016 Jul 04;8(7): PubMed
Food Chem Toxicol. 2009 Nov;47(11):2847-52 PubMed
Mol Nutr Food Res. 2007 Jan;51(1):61-99 PubMed
J Chromatogr A. 1999 Nov 12;862(2):147-59 PubMed
Arch Toxicol. 2000 Nov;74(9):499-510 PubMed
Arch Toxicol. 2016 Nov;90(11):2595-2615 PubMed
Can Urol Assoc J. 2013 Sep-Oct;7(9-10):319-23 PubMed
Mol Nutr Food Res. 2006 May;50(6):519-29 PubMed